98%
921
2 minutes
20
: The global outbreak caused by the SARS-CoV-2 pandemic disrupted healthcare worldwide, impacting the organization of intensive care units and surgical care units. This study aimed to document the daily neurosurgical activity in Alsace, France, one of the European epicenters of the pandemic, and provide evidence of the adaptive strategies deployed during such a critical time for healthcare services. : The multicentric longitudinal study was based on a prospective cohort of patients requiring neurosurgical care in the Neurosurgical Departments of Alsace, France, between March 2020 and March 2022. Surgical activity was compared with pre-pandemic performances through data obtained from electronic patient records. : A total of 3842 patients benefited from care in a neurosurgical unit during the period of interest; 2352 of them underwent surgeries with a wide range of pathologies treated. Surgeries were initially limited to neurosurgical emergencies only, then urgent cases were slowly reinstated; however, a significant drop in surgical volume and case mix was noticed during lockdown (March-May 2020). The crisis continued to impact surgical activity until March 2022; functional procedures were postponed, though some spine surgeries could progressively be performed starting in October 2021. Various social factors, such as increased alcohol consumption during the pandemic, influenced the severity of traumatic pathologies. The progressive return to the usual profile of surgical activity was characterized by a rebound of oncological interventions. Deferrable procedures for elective spinal and functional pathologies were the most affected, with unexpected medical and social impacts. : The task shifting and task sharing approaches implemented during the first wave of the pandemic supported the reorganization of neurosurgical care in its aftermath and enabled the safe and timely execution of a broad spectrum of surgeries. Despite the substantial disruption to routine practices, marked by a significant reduction in elective surgical volumes, comprehensive records demonstrate the successful management of the full range of neurosurgical pathologies. This underscores the efficacy of adaptive strategies in navigating the challenges imposed by the largest healthcare crisis in recent history. Those lessons will continue to provide valuable insights and guidance for health and care managers to prepare for future unpredictable scenarios.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10972217 | PMC |
http://dx.doi.org/10.3390/medicina60030390 | DOI Listing |
Org Biomol Chem
September 2025
Laboratoire d'Innovation Moléculaire et Applications (LIMA), Univ. de Strasbourg, Univ. de Haute-Alsace, CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67000 Strasbourg, France.
,-glycosides--glycosides characterized by two carbon substituents at the pseudo-anomeric position-constitute a structurally distinctive class of glycomimetics with growing relevance in natural products and drug discovery. These motifs appear in diverse bioactive compounds such as maitotoxin, nogalamycins, zaragozic acids and remdesivir, displaying antimicrobial, anti-inflammatory, and anticancer properties. The unique architectures of ,-glycosides expand the glycochemical space and hold promise for therapeutic development.
View Article and Find Full Text PDFTicks Tick Borne Dis
September 2025
Service de Maladies Infectieuses et Tropicales Hôpital Civils de Colmar, 39 avenue de la liberté 68024 Colmar, France; Service de Maladies Infectieuses et Tropicales Hôpitaux universitaires de Strasbourg, Nouvel Hôpital Civil quai Louis Pasteur, 67000 Strasbourg France; Université de Strasbourg
Tularemia is a bacterial zoonosis endemic to the Northern Hemisphere, transmitted through various modes and presenting with diverse clinical manifestations. In recent years, the number of notifications (tularemia is a reportable disease in France) have increased and the spectrum of clinical forms have changed. We conducted a retrospective study of tularemia incidence diagnosed in 2024 at two major hospitals in Alsace, a small region of Northeastern France.
View Article and Find Full Text PDFNanotechnology
September 2025
IS2M, Universite de Haute-Alsace, Faculte des Sciences et Techniques, 3bis rue Alfred Werner, F-68093 Mulhouse Cedex, Mulhouse, Grand Est, 68093, FRANCE.
The formation of one dimensional (1D) semiconductors offers exciting potential for the development of nanoscale devices. Germanium (Ge) nanoribbons can be formed on metallic substrates with specific structural and electronic properties. In this study, we investigate the structure of Ge nanoribbons grown on an Al(110) substrate by molecular beam epitaxy (MBE).
View Article and Find Full Text PDFBr J Dermatol
September 2025
Université Bourgogne Europe, INSERM, CTM UMR1231, Equipe GAD, Dijon, France.
Clin Genet
October 2025
Department of Neuropediatrics, CréER, ERN EpiCare, Strasbourg University Hospitals, Strasbourg, France.
We report the first known case of a 9-year-old male with early-onset epilepsy, syncope, and ictal asystole-requiring pacemaker implantation at the age of seven-associated with a pathogenic variant in FGF12.
View Article and Find Full Text PDF